The significant miss in both earnings and revenue expectations for Macrogenics is likely to negatively impact investor sentiment in the short term. Historically, earnings performance has been a key driver of stock price movements. Given the magnitude of the miss and the historical context of how past earnings beats led to stock price increases, it's reasonable to expect a negative reaction in the stock price.